Neurologic Involvement in Primary Immunodeficiency Disorders

Abstract

The nervous system may be affected in primary immune deficiency (PID) syndromes through infectious, autoimmune, neoplastic mechanisms, or as a primary feature of the syndrome. However certain neurologic problems do not conform to these etiopathogenetic groups. We retrospectively examined PID patients seen in neurology consultation between 2014 and 2017 in order to determine the spectrum of nervous system involvement. Among patients with confirmed neurologic problems (n = 35), common manifestations were encephalopathy and global developmental/cognitive delay. In 13 (37%) instances, the neurologic signs had no apparent relation with a treatment-related, infectious, or vascular complication and were considered as primary findings: acquired microcephaly, central nervous system malformation, or peripheral neuropathy. The diagnosis of PID was made after, and based on, the neurologic manifestation in 6 of 35 (17%) patients. Neurologic presentation may constitute the initial manifestation in some types of primary immune deficiency.

Keywords

primary immune deficiency immunosuppression agammaglobulinemia neurologic nervous system

Get full access to this article

View all access options for this article.

References

Dehkordy

Aghamohammadi

Ochs

. Primary immunodeficiency diseases associated with neurologic manifestations. J Clin Immunol. 2012;32:1–24.

Picard

Al-Herz

Bousfiha

. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35:696–726.

Dale

Brilot

Duffy

. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014;83:142–150.

Zhou

Yang

Ombrello

. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911–920.

Lopez-Herrera

Tampella

Pan-Hammarström

. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90:986–1001.

Levy

Stolzenberg

Bruneau

. LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritis. Clin Immunol. 2016;168:88–93.

Leaes

Rios

Passaglia

. Autoimmune polyglandular syndrome: an unusual presentation with empty sella, premature ovarian failure, and Hashimoto’s thyroiditis associated with thyroid cancer. Gynecol Endocrinol. 2012;28:999–1001.

Sag

Saka

Ozgur

. Progressive neurodegenerative syndrome in agammaglobulinemia. Cogn Behav Neurol. 2014;27:155–159.

Ziegner

Kobayashi

Cunningham-Rundles

. Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol. 2002;102:19–24.

10.

Quan

Wagner

Briese

. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis. 2010;16:918–925.

11.

Nofech-Mozes

Blaser

Kobayashi

. Neurologic abnormalities in patients with adenosine deaminase deficiency. Pediatr Neurol. 2007;37:218–221.

12.

Myers

Hershfield

Neale

. Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J Pediatr. 2004;145:710–712.

13.

Brodszki

Svensson

van Kuilenburg

. Novel genetic mutations in the first Swedish patient with purine nucleoside phosphorylase deficiency and clinical outcome after hematopoietic stem cell transplantation with HLA-matched unrelated donor. JIMD Rep. 2015;24:83–89.

14.

Mansouri

Min

Cole

. Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice. Neurobiol Dis. 2012;47:201–209.

15.

Ozkinay

Pehlivan

Onay

. Purine nucleoside phosphorylase deficiency in a patient with spastic paraplegia and recurrent infections. J Child Neurol. 2007;22:741–743.

16.

Zhang

Bogunovic

Payelle-Brogard

. Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature. 2015;517:89–93.

17.

Potjewijd

de Paus

van Wengen

. Disseminated Mycobacterium genavense infection in a patient with a novel partial interleukin-12/23 receptor β1 deficiency. Clin Immunol. 2012;144:83–86.

18.

Cagdas

Yilmaz

Kandemir

. A novel mutation in leukocyte adhesion deficiency type II/CDGIIc. J Clin Immunol. 2014;34:1009–1014.

19.

Gazit

Mory

Etzioni

. Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol. 2010;30:308–313.

20.

Yang

Muzny

Xia

. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA. 2014;312:1870–1879.